Malignant Gastric Neoplasm — Trials

Malignant Gastric Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 652
Recruiting: 352
Ph III recruiting: 49
Growth YoY: +15.1%
Industry share: 26%
Top sponsor: Fudan University
Termination share: 26.2%
Trials / 1,000 deaths: 59.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (232)

clinicaltrialsPublishedShowing 151–165 of 165 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06640153	MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma	active not recruiting	—	100	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	1	Oct 15, 2024	clinicaltrials
NCT05215574	Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors	active not recruiting	Phase 1	130	NGM Biopharmaceuticals, IncINDUSTRY	1